Prothena Archives -

Diabetes giant Novo Nordisk has opened a new front in its rare disease R&D, thanks to an acquisition

Novo Nordisk bulks up in rare diseases with $1.2bn Prothena deal

https://pharmaphorum.com/news/novo-nordisk-bulks-up-in-rare-diseases-with-1-2bn-prothena-deal/

Just a few days after Biogen abandoned its tau-targeting Alzheimer’s disease candidate gosuranemab, Bristol-Myers Squibb has opted into

BMS re-joins Alzheimer’s push, paying $80m for Prothena’s tau antibody

https://pharmaphorum.com/news/bms-re-joins-alzheimers-push-paying-80m-for-prothenas-tau-antibody/

Dublin biotech to focus on neurology drugs

Prothena axes half its staff after phase 3 catastrophe

https://pharmaphorum.com/news/prothena-axes-staff-phase-3-catastrophe/

Prothena